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Abstract
Selenium is an essential trace element incorporated into selenoproteins as selenocysteine. Selenocysteine (Sec) lyases (SCLs)
and cysteine (Cys) desulfurases (CDs) catalyze the removal of selenium or sulfur from Sec or Cys, respectively, and generally
accept both substrates. Intriguingly, human SCL (hSCL) is specific for Sec even though the only difference between Sec and
Cys is a single chalcogen atom. The crystal structure of hSCL was recently determined and gain-of-function protein variants
that also could accept Cys as substrate were identified. To obtain mechanistic insight into the chemical basis for its
substrate discrimination, we here report time-resolved spectroscopic studies comparing the reactions of the Sec-specific
wild-type hSCL and the gain-of-function D146K/H389T variant, when given Cys as a substrate. The data are interpreted in
light of other studies of SCL/CD enzymes and offer mechanistic insight into the function of the wild-type enzyme. Based on
these results and previously available data we propose a reaction mechanism whereby the Sec over Cys specificity is
achieved using a combination of chemical and physico-mechanical control mechanisms.
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Introduction
Selenium is the only trace element found in proteins that is
directly genetically encoded. The semi-metal is incorporated into
selenoproteins in the form of selenocysteine (Sec) by a co-
translational process using an intricate translation mechinery that
redefines specific UGA codons to encode Sec [1,2]. Selenium can
also be severely toxic because of the high chemical reactivity of
metabolites such as selenite and hydrogen selenide [3,4,5]. Thus it
is vital to both have adequate selenium intake and to develop
means for tight control of the selenium metabolism. Sec ingested in
the diet is not directly loaded on its tRNA for subsequent
incorporation in selenoproteins. Instead, Sec is first degraded by
Sec lyase (SCL) that can provide the selenide precursor for




Sec lyases (SCLs) and Cys desulfurases (CDs) catalyze the
removal of selenium or sulfur from Sec or Cys and generally act on
both substrates. Importantly, however, human SCL (hSCL) as well
as SCLs from other higher eukaryotes are specific for Sec and do
not accept the sulfur analogue Cys as substrate. Instead, hSCL is
inhibited by addition of excess Cys [9,12,13,14,15].
The enzymatic mechanism for CD enzymes was originally
delineated by Zheng et al. This has since served as a model for
several mechanistic proposals for SCL and CD proteins resulting
in a consensus mechanism (Fig. 1), with some studies suggesting a
variant of the mechanism in that the SH or Se
2 is eliminated
directly from the Sec/Cys quinonoid intermediate (red dotted
arrows in Fig. 1) [10,15,16,17,18,19,20,21,22,23,24].
Still, the structural and chemical basis for the important
selenium specificity of eukaryotic SCLs remains unclear. A recent
study of SCL from rat (rSCL) reported slightly different binding
modes for Cys and the Sec substrate analogue selenopropionate
and suggested this to be the basis for specificity. Cys was reported
to reversibly form a nonproductive adduct with rSCL while
selenopropionate bound in two different conformations [25].
However, the guiding mechanism and whether the binding is
influenced by the lack of the amine on the Sec substrate analogue
used remains an open question.
In an accompanying study, using a structure-guided bioinfor-
matic approach, we produced gain-of-function protein variants of
hSCL that also show CD activity. Among the protein variants
tested, a D146K variation was necessary and sufficient to obtain
CD activity in hSCL [26]. The aim of this study is to benefit from
these results to gain further insight into the mechanism of SCL/
CD enzymes and the chemical basis for selenium specificity in
hSCL. Here we report time-resolved spectroscopic characteriza-
tion of the selenium-specific wild-type (WT) hSCL in comparison
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function for Cys cleavage. The double mutant was choosen for
study because it showed slightly higher activity than the D146K
single mutant [26]. The data indicate that the wild type and active
variant proteins behave similarly in the early steps of the reaction
while differences are observed in later stages. Based on these
results and previously available data, we hypothesize a reaction
mechanism including a chemical specificity step that provides the
selenium specificity of hSCL.
Results
Gain-of-function variants
We found that in contrast to wild type hSCL, which has a very
low activity with Cys as substrate, a mutation of D146 into Lys
resulted in a gain-of-function variant with both Sec lyase and Cys
desulfurase activity. The structural determinants for this activity
were studied in an accompanying paper [26]. Here, we wished to
provide further insight into the chemical basis for this specificity
Figure 1. Consensus mechanism in SCL/CD enzymes and related systems, a variation of the mechanism, proposed in some studies
is indicated by red dotted arrows [10,15,16,17,18,19,20,21,22,23,24]. Shown in the scheme are the Sec/Cys substrates, the presumed
interaction with the PLP cofactor, and the active site Cys residue accepting either sulfur or selenium. The intermediate species denoted as ‘‘State 0’’,
‘‘State I’’ and ‘‘State II’’ are further discussed in the text.
doi:10.1371/journal.pone.0030528.g001
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H389T was choosen for study because it showed slightly higher
activity with Cys than the D146K single mutant [26].
Time-resolved UV/Vis spectroscopy. To investigate how
the gain-of-function substitution influenced the mechanism, and
thus the chemical background to the selenium specificity of the
wild-type protein, we performed spectral analyses and stopped-
flow UV/Vis spectroscopic investigations of the reaction of the
wild-type and D146K/H389T variant proteins using Cys as
substrate (Fig. 2A–F and Fig. 3 A–D). The UV-visible spectrum of
the as isolated (in 120 mM Tris pH 8.5 and 2 mM TCEP) wild-
type and variant proteins showed similar spectra with an
absorption peak at ,410 nm with only a slight shoulder in the
300–350 nm region (Fig. 2A), which was very similar to what has
been observed in other NifS homologs [15,27]. This reveals that
the Shiff base linking the PLP cofactor to the protein exists mainly
in the protonated, ketoenamine, form of the internal aldimine
species (Fig. 1, ‘‘state 0’’) [18,28].
The enzyme solution was mixed with Cys to final concentra-
tions of 20 mM enzyme and 10 mM Cys in a stopped-flow
apparatus. The first spectrum, obtained immediately after mixing
(,1 ms mixing time), displayed major peaks at ,360 nm and
420 nm and a minor contribution at ,395 nm with both proteins
behaving virtually identical on this short time scale (Fig. 2B). At
0.5 sec the wild type spectrum remained basically unchanged but
with a slight net decline of the 360 nm peak and accumulation of
the 420 nm peak. The variant protein, on the other hand, showed
a decline of the 420 nm peak (Fig. 2C). After 0.5 s both spectra
remained qualitatively unchanged in the minute regime
(Fig. 2D,E), but displaying a slow decline of the 420 nm peak
over several minutes. After long incubation (500 s) both systems
appeared to have reached quasi-steady state with absorbance
contributions from all states of the reaction in their respective
equilibrium concentrations.
To determine the kinetics of the specific reaction steps, we
measured the time-dependent absorbance changes for both
protein variants up to 500 ms (Fig. 3). Note that these traces
show the differences in absorbance after mixing. The absorbance
at time=0 was set to zero independently of the actual value, which
means that the absolute absorbance values at different wavelengths
can not be directly compared. Time constants obtained by fitting
the data are also shown. The very rapid decay in absorbance at
420 nm coincides in time with the mixing time of the instrument,
estimated at ,1 ms, and therefore the time constant of the
corresponding reaction could only be estimated at #1 ms. For the
wild type protein, three distinct phases were observed, firstly a very
rapid phase (#1 ms) indicated by a decline in the 420 trace. Next,
the absorbance increased at 420 nm and decreased at 360 nm
with a time constant of ,10 ms. Finally, a phase with a time
constant estimated at .50 ms was observed as a small increase at
360 nm. The traces for the variant protein show an initial rapid
(#1 ms) decrease at 420 nm, followed in time by an increase in
absorbance at 360 nm with a time constant of 29 ms.
The combined spectroscopic data can be described by the
model in figure 4. The transition from the 410 nm absorbance of
the as-isolated protein (‘‘State 0’’, Fig. 4) to the 360 nm (‘‘State I’’,
Fig. 4) and 420 nm (‘‘State II’’, Fig. 4) absorbances dominating at
1 ms must be very fast and is not observed in the absorbance
difference traces. We conclude that this phase was rapid and over
within the mixing time of the instrument (,1 ms) for both
proteins. A decay of the 420 nm absorbance is however observed
just after t=0 for both proteins (Fig. 3C). Following these very
rapid phases, an absorbance decay at 360 nm was observed in the
wild-type protein concomitant with an increase in absorbace at
420 nm with a time constant of ,10 ms (Fig. 3A, C). In the
D146K/H389T variant enzyme this phase was not observed, still,
the 420 nm absorbing species is present with similar amplitude in
both spectra at 1 ms (Fig. 2B). The most likely interpretation of
this data is that the 420 nm absorbance observed in the wild-type
protein is a result of more than one species of which one is formed,
and decays, fast (as in the variant protein) and one is slower in its
formation and accumulates with a time constant of ,10 ms. Due
to the qualitatively similar spectra we presume that the same early
intermediate species were produced in both proteins. After the
initial phases, we observe a phase in the D146K/H389T protein
with a time constant of ,29 ms, seen as an increase in absorbance
at 360 nm (Fig. 3B). Indication of a similar absorbance increase
can also be observed in the wild-type enzyme. It was difficult to
accurately estimate the time constant of this phase, but we
conclude that it is slower (.50 ms) and, based on the smaller
increase in absorbance, appears to represent only a fraction of the
sample.
The difference spectra at longer timepoints 0.5, 10, 50 and
500 sec (Fig. 2C–F) reveal that there is at least one more phase
observed, characterized by a very slow drop in the absorbance at
420 nm, until the systems reach equilibrium.
Discussion
The properties of the initial species absorbing at 360 nm (‘‘State
I’’, Fig. 4), together with its rapid formation (cf. Fig. 2A and 2B),
make the substrate gem-diamine species (Fig. 1) the most likely
explanation for this absorbance [17,18,19,24,29,30]. Based on the
general reaction scheme, the rapidly forming 420 nm absorbing
species in both systems (Fig. 2B) most likely result from the
external Cys-aldimine (‘‘State II’’, Fig. 1). The minor peak at 390–
395 nm should be consistent with a small amount of free PLP in
solution, possibly liberated from the enzyme. After the initial very
fast phases, we observe an accumulation of the absorbance at
420 nm in the wild type protein with a time constant of ,10 ms
(Fig. 3C, ‘‘State IIIwt’’ in Fig. 4). The identity of this species is
difficut to assign because several intermediates are expected to
absorb at this wavelength, moreover, it may also represent a
species that is not part of the normal catalytic pathway. After this
phase we see a gradual recovery of the absorbance at 360 nm with
a time constant of ,30 ms in the variant enzyme and .50 ms in
the wild type protein. At this stage the spectra are expected to
contain contributions from several intermediate states that also
absorb at similar wavelengths. Finally, we observe a very slow
phase, characterized by a decrease in absorbance at 360 nm, until
the systems reach equilibrium. The last spectra at 500 s should
represent both systems in equilibrium with excess cysteine. Here,
all states of the protein contribute to the spectrum based on their
relative abundance in the sample. It is also possible that various
other species, such as thiol adducts observed in the rat enzyme,
which are not part of the direct catalytic pathway but known to
form in these systems contribute to the spectra [24,25,29]. Even if
such dead-end substrate-enzyme species contribute statically to the
spectra this would not influence the time constants observed in the
transition between different species of the pathway. The time
constants of the observed phases are also reasonable when
compared with previously published catalytic parameters for
SCL/CD enzymes [12,13,15,24].
Mechanism of selenium specificity
Previous investigations of the mechanism of SCL/CD enzymes
and related systems show that the first step is the binding of
substrate to form the PLP external aldimine, followed by
Selenium Specificity of Human Selenocysteine Lyase
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30528deprotonation of the substrate. Eventually, a PLP-substrate
intermediate is attacked by a deprotonated active site Cys,
producing the protein-bound persulfide or sulfoselenide (Fig. 1)
[10,15,16,17,18,19,20,21,22,23,24]. The spectroscopic data with
excess Cys presented here is in good agreement with previous
studies and the proposed general mechanism presented in figure 1.
Still, because of the complexity of the reaction, with several
different intermediates absorbing at similar wavelengths, it is not
Figure 2. Spectroscopic data for the wild-type and the D146K/H389T variant proteins. A) Spectra of as-isolated proteins taken in a
scanning spectrophotometer. B–F) Diode-array stopped flow spectra 0.001, 0.5, 10, 50 and 500 sec after addition of 10 mM Cys. Reference lines are
drawn at 360, 395, 410 and 420 nm.
doi:10.1371/journal.pone.0030528.g002
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type enzyme, explaining its low turnover with Cys. However, it
appears to be in a step subsequent to formation of the external
Cys-aldimine intermediate and we conclude that a very long-living
absorbance at 420 nm accumulates to a larger extent in the
inactive wild type protein, compared to the D146K/H389T
variant having a gain-of-function allowing it to use Cys as well as
Sec [26].
A hypothetical explanation for the Sec specificity of hSCL could
be that the reaction with Cys is a single-turnover reaction,
producing a dead-end protein adduct. The stopped-flow data as
such can not allow a strict distinction of whether or not a single-
turnover reaction has occurred in the WT protein. Also, single
turnover experiments were not possible because of the high Km of
SCL for free Sec/Cys [12,13]. However, we find this alternative
unlikely as the basis for specificity because this implies that Cys
would function as a suicide substrate. This does not seem to be the
case based on published activity data [9,12,13] and moreover, it
would mean that any newly synthesized protein in the cell would
immediately be inactivated by reaction with Cys, that is much
more abundant than Sec.
An important clue as to the chemical background for the Sec-
over-Cys specificity of hSCL comes from a study of the Cys
desulfurase from Synechocystis sp. PCC 6803 (SyCD) and its inactive
C325A variant [29] (C325 in SyCD corresponds to C388 in
hSCL). Upon addition of Cys, these proteins show a behavior
highly similar to what we observe for the D146K/H389T variant
and wild type hSCL, respectively. In the C325A variant of SyCD,
an absorbance profile with maxima of rougly equal absorbances at
,340 and ,417 nm develop within 80 ms and the corresponding
state is stable in the minute regime. Based on a number of different
observations, this species is assigned as the Cys aldimine and Cys
Figure 3. Absorbance difference traces at 360 nm (A, B) and 420 nm (C, D) upon addition of Cys as a function of time for the wild-
type and D146K/H389T variant proteins. Panels (A, C) 0–125 ms, panels (B, D) same wavelength up to 500 ms. Note that these traces show the
differences in absorbance after mixing. The absorbance at time=0 was set to zero independently of the actual value, which means that the absolute
absorbance values at different wavelengths can not be directly compared. Time constants, determed from fits with a sum of exponential functions,
are also given.
doi:10.1371/journal.pone.0030528.g003
Figure 4. Model describing the observed transitions in the
reaction of WT hSCL and the D146K/H389T variant protein
with excess cysteine as inferred from in the combined
spectroscopic data. Discussion of the possible nature of ‘‘State 0’’,
‘‘State I’’ and ‘‘State II’’ are found in the text and also identified in
Figure 1.
doi:10.1371/journal.pone.0030528.g004
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tion because of the lack of the attacking cysteinyl sidechain [29]. In
WT SyCD, on the other hand, the spectrum is very similar to the
hSCL active variant protein and dominated by the low wavelength
absorbance. Taken together, the spectroscopic data and the
observation that WT hSCL behaves similarly to the SyCD C325A
variant suggests that the lack of activity results from that C388 in
WT hSCL is, for some reason, incapable of attacking the PLP-Cys
intermediate.
The D146K/H389T variant showed slightly increased activity
compared to the D146K single mutant [26]. H389 directly follows
C388 in the sequence and also directly interacts with both D146
and C388 in the structure; it is thus not surprising that this
variation may influence the activity slightly. However, as shown in
the accompanying paper [26], the D146K variation was necessary
and sufficient to provide CD activity to hSCL and it is clear that
this is the key change to obtain CD activity. How may then D146
influence the attacking step to prevent desulfuration, while it
becomes possible in the D146K variant protein? Our current
working hypothesis and reasoning is described as follows.
The crystal structure revealed that D146 interacts directly with
C388 and is located on its opposite side in relation to the PLP
cofactor and the substrate-binding site (Fig. 5A) [26]. This suggests
that the effect of the D146K substitution is exerted through
influencing C388 rather than affecting either the PLP cofactor or
the substrate as such. A negatively charged Asp, as in the proteins
specific for Sec, interacting with C388 should destabilize a
deprotonated state while a positively charged Lys (as in other
group I proteins) is expected to stabilize it (Fig. 6 boxes). In the
group II CD/SCL proteins the corresponding residue is a His,
which could serve as a base for hydrogen abstraction from the
active site Cys and also stabilize the deprotonated form. Major
differences between the two alternative substrates (Sec and Cys)
must also be taken into account. With Sec acting as an ‘‘extreme
Cys’’, it should be noted that Se may be viewed as significantly
more electrophilic than S [31,32], while it is also clear that on the
same time Sec is also more polarizable and nucleophilic than Cys
[33] and a better leaving group more resistant to overoxidation
[34]. Moreover, free Sec has a pKa of around 5.2 and is thus
deprotonated at physiological conditions while for free Cys its pKa
is around 8.3, leaving it mainly protonated. Even though Sec or
Cys side chains within proteins may have significantly altered pKa
values and that nucleophilicity/electrophilicity is not directly
related to pKa [33], both the specific nucleophilicity/electrophi-
licity character and the large relative difference of ,3 pH units
may likely play a role for the substrate specificity of hSCL. For a
nucleophilic attack of C388 to occur using Cys as an electrophilic
substrate, the active site C388 residue needs to be deprotonated to
form a Cys-persulfide [16,17,18,19,24,30]. For Sec as substrate, on
the other hand, it would be expected that the protonation state of
C388 will be less critical, or even preferred to be in the protonated
Figure 5. A) Position of residues D146K, V256S and H389T in relation to
C388 and the PLP cofactor in the structure of hSCL (PDB id 3GZC). B)
Superposed subunits A and B of human SCL (PDB id 3GZC) showing the
structural differences in the active site segment and positioning of C388
(subunit A: pink ‘‘closed’’ and subunit B: cyan ‘‘open’’), the location of
Asp 146 is also shown.
doi:10.1371/journal.pone.0030528.g005
Figure 6. Proposed specificity step in hSCL shown with gray
background, hSCL numbering. In non-specific enzymes the residue
corresponding to 146 in hSCL is K in Group-I and H in Group-II SCL/CD
proteins. The figure is drawn based on the mechanism involving
elimination from the ketimine intermediate, originally proposed by
Zheng et al. [16]. However, the same reasoning is equally valid also for
the alternative mechanism with elimination directly from the quinonoid
intermetiate (Fig. 1, red dotted arrows).
doi:10.1371/journal.pone.0030528.g006
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nucleophilic. In addition, a protonated C388 is clearly a better
electrophile than a deprotonated C388, whereby the reaction
would be expected to benefit from a more reactive substrate, such
as Sec. Moreover, the completely conserved H145 and the
positively charged ketimine nitrogen of the cofactor-substrate
complex may be particularly effective to activate the Sec substrate
because of the high polarizability of Se. Figure 6 illustrates the
possible scenarios, for different substrates and the hSCL protein
variants, in the step of the mechanism where C388 reacts with the
substrate. Figure 6 is drawn based on the chemical mechanism
involving elimination from the ketimine intermediate, originally
proposed by Zheng et al. [16]. However, the same reasoning is
equally valid also for the alternative shorter mechanism with
elimination directly from the quinonoid intermetiate. Hence, we
propose that Sec specificity over Cys occurs in hSCL because
C388 is maintained in its protonated form, thus only reacting
when Sec is bound to the PLP.
In addition, as described in the accompanying paper, group-I
SCL/SD proteins contain a dynamic active site segment that
houses the active site Cys residue. The location of D146 in relation
to the dynamic active site segment [26] also appears ideally suited
to impose a second level of control (Fig. 5B). In the closed
conformation the sulfur atom of C388 is located ,4A ˚ from D146,
more or less in van der Waals contact, while in the open form this
distance is ,10 A ˚. A deprotonated, negatively charged, C388 is
thus likely to shift the equilibrium towards the open or disordered
state of the dynamic segment because of electrostatic repulsion
from D146. This physico-mechanical mechanism is thus an
additional and complementary way by which D146 may reduce
the probability of positioning a deprotonated C388 in the closed
conformation, as needed to react with Cys positioned into its
substrate-binding cleft. Using the mechanisms described above as
the basis for specificity should not yield a reaction that is strictly
specific over infinite time scales because C388 would be
deprotonated and located in the closed conformation a fraction
of the time, depending on its local pKa, the pH, and the dynamics
of the residue and active site domain. This is consistent with the
observation of a C388-persulfide in the high-pH (P1) crystal form
after a 2 h Cys soak [26] and the previously shown inhibition of
the enzyme by Cys [9,12,13,14,15].
The results presented here are partially in contrast with the
recent study of rSCL [25]. Instead of seeing an unproductive
complex with Cys upon soaking as in rSCL (crystallized at pH 4.7
and soaked at pH 8.0), we observed the partial formation of a
C388 persulfide after extended incubation of hSCL crystals with
Cys (crystallized and soaked at pH 8.1) [26]. In addition, the
stopped-flow data with hSCL and the variant protein with gained
CD activity, shown herein, point to a chemical mechanism for the
specificity in a step following initial substrate binding, rather than
in the substrate binding itself. Still, it cannot be ruled out that
several mechanisms work together or that there are mechanistic
differences between hSCL and rSCL. In the in vivo scenario,
where Cys may bind hSCL and thus block its active site and PLP
cofactor availability for catalysis with Sec, other mechanisms e.g.
direct protein-protein delivery facilitating Sec binding over Cys
may also be in effect.
Conclusions
Because of their similar chemical properties, the important
discrimination between sulfur and selenium under physiological
conditions has remained enigmatic. By studies of the Sec over Cys
specificity of hSCL and the gain-of-function D146K/H389T
protein variant, we here propose a possible mechanistic basis for a
Sec-specific enzymatic reaction not accepting Cys as substrate. In
this suggestion, the specificity is achieved by a combination of
chemical and physico-mechanical control mechanisms, thereby
exploiting the intrinsic chemical properties of the elements Se and
S.
Materials and Methods
Cloning, construction of protein variants, expression and
purification was performed as described in the accompanying
paper [26]. In short, the hSCL cDNA clone was purchased from
the Mammalian Gene Collection (Genebank accession
no. BC007891.2). The sequence encoding residues 8–445 was
amplified by PCR and inserted into pNIC-Bsa4 vector (Genbank
accession no. EF198106). The construct included an N-terminal
His6 tag for purification. Variant SCLY constructs were made by
using the Stratagene QuikChangeH Multi Site-Directed Mutagen-
esis Kit using primers; D146K: 59- cctcggtggaacacaagtc-
catccggctgcc-39 and H389T: 59- ggggccgcgtgcacctcggaccacgg-39,
positions differing from wild-type are indicated in bold. After
sequence confirmation, the wild-type and variant constructs were
transformed into E.coli BL21(DE3)R3 pRARE cells and stored at
280uC as a glycerol stock. Cells from the glycerol stock were used
to inoculate 20 ml of Terrific Broth (TB) supplemented with 8 g/l
glycerol and 100 mg/ml kanamycin and grown at 30uC over night.
The 20 ml culture was used to inoculate 1.5 l TB media
supplemented with 8 g/l glycerol, 50 mg/ml kanamycin and 5
drops of BREOX anti-foaming agent (Cognis Performance
Chemicals UK Ltd) in a 2 l glass flask. Cells were grown in a
Large Scale Expression System (LEX, Harbinger Biotechnology)
at 37uC until the OD600 reached 1. The cultivation was then
cooled to 18uC for 1 h whereupon expression of hSCL was
induced by the addition of 0.5 mM IPTG and subsequently
continued over night at 18uC. Cells were harvested by centrifu-
gation at 55006 g for 10 min. at 4uC and the pellet was
resuspended in lysis buffer containing 50 mM Na-phosphate
pH 7.5, 500 mM NaCl, 10% glycerol, 10 mM imidazole, 0.5 mM
TCEP, and Complete EDTA-free protease inhibitor (Roche
Biosciences). The sample was sonicated on ice (Sonics VibraCell)
at 80% amplitude, 4 sec on, 4 sec off for a total of 3 min followed
by centrifugation at 49 0006 g for 20 min. at 4uC. The soluble
fraction was decanted and filtered through a 0.45 mm filter.
Purification of the protein was performed as a two-step process on
an A ¨KTAxpress system (GE Helthcare). First step, metal affinity
chromatography using 1 ml HiTrap Chelating column (GE
Helthcare) and second step, gel filtration using, Superdex 200
gel filtration column (HiLoad 16/60; GE Healthcare). Prior to
purification, the HiTrap Chelating column was equilibrated with
buffer1 (50 mM Na-phosphate pH 7.5, 500 mM NaCl, 10%
glycerol, 10 mM imidazole, 0.5 mM TCEP) and the Superdex
200 was equilibrated with buffer2 (20 mM Hepes pH 7.5, 300 mM
NaCl, 10% glycerol, 0.5 mM TCEP. The filtered lysate was
loaded onto the Ni-charged HiTrap Chelating column and
washed with buffer1 followed by buffer1 supplemented with
imidazole to a final concentration of 25 mM. Bound protein was
eluted from the column with buffer1 containing 500 mM imidazole
and automatically loaded onto the gel filtration column, and
subsequently eluted using buffer2. Fresh TCEP was added to the
pooled fractions to a final concentration of 2 mM. Protein identity
was confirmed by mass spectrometry. Prior to spectroscopic
measurements, the His-tag was cleaved off and removed by IMAC
chromatography. Before assaying, the protein was treated with
EDTA, which was subsequently removed by dialysis against
buffer2.
Selenium Specificity of Human Selenocysteine Lyase
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(Cys) was monitored using a stopped-flow spectrophotometer
(Applied Photophysics, Leatherhead, UK). A solution containing
20 mM Cys, 120 mM Tris pH 8.5 and 2 mM TCEP was rapidly
mixed at a ratio of 1:1 with a solution containing 40 mMo f
enzyme, 120 mM Tris pH 8.5 and 2 mM TCEP. Absorbance
changes as a function of time were monitored either at several
wavelengths simultaneously using a diode-array detector or at
single wavelengths using a photomultiplier tube. The absorbance
at time=0 was set to zero independently of the actual value, which
means that the absolute absorbance values at different wavelengths
can not be directly compared.
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